openPR Logo
Press release

Chlamydia Infection Diagnostics and Therapeutics Market Size to Observe Steady Growth

09-29-2017 12:15 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Chlamydia Infection Diagnostics and Therapeutics Market Size

The global market for chlamydia infection diagnostics and therapeutics stood at US$1,195.5 mn in 2016 and is projected to rise at a CAGR of 6.0% from 2017 to 2025 to reach a valuation of US$2,002.2 mn in 2025.

Based on the diagnostics method available for chlamydia infection, the market is segmented into nucleic acid amplification tests (NAATs), direct fluorescent tests, and PCR. Of these, the segment of NAAT held the major share accounting of more than 69.8% in 2016. NAAT tests are approved by FDA and the demand for these sensitive diagnostic tests is driven by the rising prevalence of chlamydia. Regionally, North America market held the major share of 55.5% of the global infection diagnostics market and accounted for more than 44.5% of the infection therapeutics market in 2016.

The rising incidence of chlamydia infection, expanding screening coverage, and the phenomena of more complete reporting, especially in developed nations, are crucial factors boosting the demand for infection therapeutics market. The growing number of academic research, vast rise in healthcare spending in developed and developing countries in screening for sexually-transmitted diseases, and the increasing prevalence of the infection are the key driving the global chlamydia infection diagnostics and therapeutics market. The noted risk of the infection among young men and women attributed to various biological factors has bolstered the demand for the infection diagnostics. In addition, the availability of more sensitive diagnostic tests has led to a growing number of reported cases of the infection.

The advent of advanced, efficacious therapeutics is a significant factor expected to boost the market. In addition, the nature of chlamydial infections being asymptomatic, particularly among women, has led to the demand for diagnostics and therapeutics to meet the demand of a burgeoning patient pool. The availability of a well-structured reimbursement policy from public and private health insurance firms and the rising awareness among young populations in developed nations, such as that in North America and Europe, has catalyzed the market growth.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8212

The social stigma associated with the screening of Chlamydia trachomatis causing Chlamydia, is evident in increased bullying and ostracism, which has resulted in several unreported cases, thereby hindering the market to an extent. This is a key factor that has discouraged young women in the age group of 16-25 and among those aged more than 25 years who are sexually active to undergo voluntary screening. Nevertheless, the prevalence of various co-morbidity factors among women, especially fatal ectopic pregnancy, has triggered the demand for the infection therapeutics and diagnostics. Furthermore, the growing resources available to support Chlamydia screenings is expected to boost the market.

The availability of advanced screening tests is likely to bolster their uptake in developing and developed regions. Furthermore, the rising commercialization of advanced products by top players and the rising awareness of Chlamydia trachomatis among women bodes well for the market.

Request to Download TOC of the Report: http://www.transparencymarketresearch.com/report-toc/8212

The global chlamydia infection diagnostics and therapeutics market is fairly consolidated as the combined share of the top five vendors in the diagnostics segment exceeded 58% of the overall market while the leading companies in the therapeutics segment accounted a share for approximately 24% in 2016, Transparency Market Research (TMR). Despite the presence of several players, the global market features a low competitive rivalry among the players. A growing number of products approved by governmental regulatory agencies in various developing and developed economies has increasingly benefitted market players. Leading players opt for expansion of their operations in potential regional markets, in a move to capitalize on emerging lucrative avenues. In addition, they are actively offering product launches, engaging in collaborations, and making strategic acquisitions to consolidate their shares in various regions.

Global Chlamydia Infection Diagnostics and Therapeutics Market Report is available @ US$ 5795 : http://www.transparencymarketresearch.com/checkout.php?rep_id=8212<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chlamydia Infection Diagnostics and Therapeutics Market Size to Observe Steady Growth here

News-ID: 748388 • Views: 288

More Releases from Transparency Market Research

Distributed Operating System Market: A Latest Research Report to Share Industry …
A distributed operating system is a software which is a collection of distinct computational nodes that are networked, independent, and communicating in order to perform certain operations The distributed operating system manages the jobs that are serviced by multiple processing units. Every distinct node holds a precise software subset of the global collective operating system. Each subset is a composite of two distinct service provisions. The first subset is a universal kernel,
Research Outlines Huge Growth In Automatic Dependent Surveillance Broadcast Mark …
Automatic dependent surveillance-broadcast (ADS-B) is surveillance technology which enables an aircraft to determine its position through satellite navigation. Automatic dependent surveillance-broadcast (ADS-B) helps to track an aircraft through periodical broadcasts. As a replacement for secondary surveillance radar, automatic dependent surveillance - broadcast (ADS–B) technology can be used by air traffic control ground stations to gather information regarding tracking of the aircraft. It can also be used by other aircrafts to enable
RF Shielded Test Enclosures Market: Structure and Overview of Key Industry
RF shielded test enclosures, also called RF shielded test boxes, are used for testing of RF and microwave devices in an isolated test environment, which lacks interference of other devices as well as the external environment These test boxes are used in isolation from unintended electromagnetic interference in noisy surroundings. In order to check whether a device is functioning up to the mark in an isolated environment, these boxes are used
Pitot Tube Anemometers Market Will Escalate Rapidly in the Near Future
A pitot tube anemometer is a flow measurement device that is designed to measure and display air pressure, air velocity, volumetric flow, and air temperature Pitot tube anemometers involve use of the microprocessor technology for signal processing, which ensures quick and accurate measuring results Pitot tube anemometers are available in two types i.e. portable and fixed When not in use, a pitot tube anemometer should be placed in dry conditions and be protected

All 5 Releases


More Releases for Chlamydia

Chlamydia Infections-Pipeline Review H2 2018
Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing factors include age, multiple sex partners and history of prior sexually transmitted infection. Treatment includes antibiotics and pain medicine. Report Highlights Publisher's Pharmaceutical and Healthcare latest pipeline guide Chlamydia Infections-Pipeline Review, H2 2018,
Chlamydia Infections Therapeutic Pipeline Market Review, H1 2018
Summary Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing factors include age, multiple sex partners and history of prior sexually transmitted infection. Treatment includes antibiotics and pain medicine. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Chlamydia Infections - Pipeline Review, H1 2018,
Chlamydia Infections Market Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chlamydia Infections - Pipeline Review, H2 2017, provides an overview of the Chlamydia Infections (Infectious Disease) pipeline landscape. Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing factors include age, multiple sex
Global Chlamydia Infection Diagnostics and Therapeutics Sales Market Report 2017
The Market Research Hub’s report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Chlamydia Infection Diagnostics and Therapeutics Sales Market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people
Chlamydia Infections Global Clinical Trials Review H1 2017
ReportsWeb.com published “Chlamydia Infections Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's clinical trial report "Chlamydia Infections Global Clinical Trials Review H1 2017" provides an overview of Chlamydia Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Chlamydia Infections.
Chlamydia Infections - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Chlamydia Infections - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chlamydia Infections - Pipeline Review, H1 2017, provides an overview of the Chlamydia Infections (Infectious Disease) pipeline landscape. Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from